Skip to content

Psilocybin: all studies

Page 440 of 440: studies 4,391 to 4,392 of 4,392, newest first. Back to the psilocybin overview

Research

Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N -Dimethyltryptamine and Harmine in a Meditation Retreat

medRxiv Klemens Egger, Daniel Meling, Firuze Polat et al. preprint

Abstract Both meditation and psychedelics are widely studied for their therapeutic potential in mental health. Recent research suggests potential synergies between mindfulness practice and psychedelics, though empirical studies have primarily focused on psilocybin. This study investigates the distinct and combined effects of mindfulness practice and an ayahuasca-inspired formulation containing...

Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging

bioRxiv (Cold Spring Harbor Laboratory) Hanna M. Tolle, Andrea I. Luppi, Timothy Lawn et al. 1 citation preprint

Conventional antidepressants show moderate efficacy in treating major depressive disorder. Psychedelic-assisted therapy holds promise, yet individual responses vary, underscoring the need for predictive tools to guide treatment selection. Here, we present graphTRIP (graph-based Treatment Response Interpretability and Prediction) – a geometric deep learning architecture that enables three...

DOI: 10.1101/2025.07.02.662710 (opens in new tab) Psychedelic therapy Depression treatment Antidepressant therapy Mdd treatment +19